Jennifer K Peterson Peter J Houghton

Contents

17.1 Introduction 267

17.2 Heterotransplant Models 268

17.2.1 Cytotoxic Agents 268

17.2.2 Signal Transduction Inhibitors 270

17.2.3 Angiogenesis Inhibitors 271

17.2.4 Viral-Based Therapies 271

17.2.5 Immunotherapy and Radioimmunotherapy 272

17.3 Transgenic Models 272

17.4 Syngeneic Models 273

17.5 Conclusion 273

References 274

0 0

Post a comment